180 related articles for article (PubMed ID: 10724795)
1. Economic evaluation of long-term management strategies for erosive oesophagitis.
Goeree R; O'Brien B; Hunt R; Blackhouse G; Willan A; Watson J
Pharmacoeconomics; 1999 Dec; 16(6):679-97. PubMed ID: 10724795
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and cost-utility of long-term management strategies for heartburn.
Goeree R; O'Brien BJ; Blackhouse G; Marshall J; Briggs A; Lad R
Value Health; 2002; 5(4):312-28. PubMed ID: 12102694
[TBL] [Abstract][Full Text] [Related]
4. Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.
Yaghoobi M; Padol S; Yuan Y; Hunt RH
Eur J Gastroenterol Hepatol; 2010 May; 22(5):583-90. PubMed ID: 20061959
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole for maintenance of remission of erosive oesophagitis.
Freston JW; Jackson RL; Huang B; Ballard ED
Drugs; 2002; 62(8):1173-84. PubMed ID: 12010078
[TBL] [Abstract][Full Text] [Related]
7. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
Moayyedi P
Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
[TBL] [Abstract][Full Text] [Related]
10. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
Sharma P; Johnson DA; Monyak JT; Illueca M
Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
[TBL] [Abstract][Full Text] [Related]
11. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
[TBL] [Abstract][Full Text] [Related]
12. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.
de Groot NL; Spiegel BM; van Haalen HG; de Wit NJ; Siersema PD; van Oijen MG
Value Health; 2013; 16(5):769-77. PubMed ID: 23947970
[TBL] [Abstract][Full Text] [Related]
13. Management strategies for gastroesophageal reflux disease.
Bak YT
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
Wahlqvist P; Junghard O; Higgins A; Green J
Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
Chiba N
Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
[TBL] [Abstract][Full Text] [Related]
16. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
Bloom BS; Hillman AL; LaMont B; Liss C; Schwartz JS; Stever GJ
Pharmacoeconomics; 1995 Oct; 8(4):343-9. PubMed ID: 10155675
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of proton pump inhibitors in the treatment of patients with endoscopic esophagitis.
Gashi Z; Haziri A; Berisha D; Zekaj S; Polloshka A; Bakalli A; Juniku A; Sadriu L
Med Arh; 2010; 64(6):362-4. PubMed ID: 21218756
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
